Nature Medicine, Published online: 09 March 2026; doi:10.1038/s41591-026-04285-xThree landmark trials confirm that fecal microbiota transplantation is a promising approach to enhancing immunotherapy efficacy in advanced solid tumors. The trials also provide insights with major implications for microbiome therapeutic development.